/BLOZF
BLOZF Stock - Cannabix Technologies Inc.
Healthcare|Medical - DevicesOTC
$0.41+14.17%
+$0.05 (+14.17%) • Dec 19
64
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.60
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.71
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.45
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for BLOZF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.41 – $0.42
TARGET (TP)$0.47
STOP LOSS$0.38
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.23
52W High$0.50
52W Low$0.20
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | $6.57M |
| Gross Profit | $-122,116 | $-153,235 | $-126,286 | $-29,217 | $-25,571 |
| Gross Margin | N/A | N/A | N/A | N/A | -0.4% |
| Operating Income | $-4,416,529 | $-2,961,618 | $-2,011,106 | $-3,114,888 | $-9,108,103 |
| Net Income | $-4,686,316 | $-3,126,607 | $-2,138,116 | $-3,367,707 | $-9,243,447 |
| Net Margin | N/A | N/A | N/A | N/A | -140.6% |
| EPS | $-0.04 | $-0.03 | $-0.02 | $-0.03 | $-0.09 |
Company Overview
Cannabix Technologies Inc., a technology company, develops marijuana breathalyzer for employers, law enforcement, governments, and public in North America. It develops tetrahydrocannabinol breath analyzers, a point of care breath testing tool for the rapid detection of recent cannabis use, as well as breath collection units. The company was formerly known as West Point Resources Inc. and changed its name to Cannabix Technologies Inc. in August 2014. Cannabix Technologies Inc. was incorporated in 2011 and is based in Burnaby, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
BLOZFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.01
Q3 2025
EPS Surprise History
Q4 23
No data
Q1 24
No data
Q3 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 16, 2026 | — | — | — | — |
Q4 2025 | Dec 18, 2025 | — | — | — | — |
Q3 2025 | Sep 23, 2025 | — | $-0.01 | — | — |
Q2 2025 | Jun 18, 2025 | — | $-0.02 | — | — |
Q1 2025 | Mar 17, 2025 | — | $-0.00 | — | — |
Q4 2024 | Dec 20, 2024 | — | $-0.00 | — | — |
Q3 2024 | Aug 27, 2024 | — | $-0.01 | — | — |
Q3 2024 | Jul 29, 2024 | — | $-0.01 | — | — |
Q1 2024 | Mar 18, 2024 | — | $-0.00 | — | — |
Q4 2023 | Dec 15, 2023 | — | $-0.01 | — | — |
Q3 2023 | Sep 26, 2023 | — | $-0.00 | — | — |
Q3 2023 | Aug 25, 2023 | — | $-0.00 | — | — |
Q1 2023 | Mar 29, 2023 | — | $-0.00 | — | — |
Q4 2022 | Dec 22, 2022 | — | $-0.00 | — | — |
Q3 2022 | Sep 22, 2022 | — | $-0.00 | — | — |
Q3 2022 | Aug 17, 2022 | — | $-0.01 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.01 | — | — |
Q1 2022 | Jan 31, 2022 | — | $-0.01 | — | — |
Q3 2021 | Jul 31, 2021 | — | $-0.00 | — | — |
Q2 2021 | Apr 30, 2021 | — | $-0.00 | — | — |
Latest News
Washington Post Reported President Trump Expected To Announce A Medicare Pilot Program To Reimburse Patients' CBD Treatments
📈 PositiveBenzinga•Dec 18, 2025, 12:21 PM•Also: , ,
'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report
📈 PositiveBenzinga•Dec 17, 2025, 01:38 PM•Also: , ,
Frequently Asked Questions about BLOZF
What is BLOZF's current stock price?
Cannabix Technologies Inc. (BLOZF) is currently trading at $0.41 per share. The stock has moved +14.17% today.
What is the analyst price target for BLOZF?
No analyst price targets are currently available for this stock.
What sector is Cannabix Technologies Inc. in?
Cannabix Technologies Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.
What is BLOZF's market cap?
Cannabix Technologies Inc. has a market capitalization of $0.05 billion, making it a small-cap company.
Does BLOZF pay dividends?
No, Cannabix Technologies Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAIRDF
Rocket Doctor AI Inc.
$0.52
Mkt Cap: $0.0B
CRRVF
CVR Medical Corp.
$0.00
Mkt Cap: $0.0B
CXXIF
C21 Investments Inc.
$0.32
Mkt Cap: $0.0B
ELIXF
Elixxer Ltd.
$0.04
Mkt Cap: $0.0B
INNMF
Amplia Therapeutics Limited
$0.08
Mkt Cap: $0.0B
OTLC
Oncotelic Therapeutics, Inc.
$0.09
Mkt Cap: $0.0B
RDGL
Vivos Inc.
$0.07
Mkt Cap: $0.0B
RLFTF
Relief Therapeutics Holding AG
$2.70
Mkt Cap: $0.0B
SNNVF
Sunniva Inc.
$0.00
Mkt Cap: $0.0B
TLTFF
Theralase Technologies Inc.
$0.12
Mkt Cap: $0.0B
Explore stocks similar to BLOZF for comparison